Interestingly, the effects of blocking CCN2/CTGF in neuromuscular diseases are not limited to reduced fibrosis and improved skeletal muscle pathology but can also improve or protect neuronal inputs (Fig. 1). This evidence concerns the gene CCN2 and neuromuscular disease.